{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:40:18Z","timestamp":1774262418656,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.canrad.2014.11.011","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T18:20:37Z","timestamp":1426011637000},"page":"98-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chimioradioth\u00e9rapie pr\u00e9op\u00e9ratoire du cancer du rectum\u00a0: exp\u00e9rience d\u2019un centre"],"prefix":"10.1016","volume":"19","author":[{"given":"N.","family":"Lescut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lepinoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schipman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Cerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Guimas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bednarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"Bosset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2014.11.011_bib0005","series-title":"\u00c9tude \u00e0 partir des registres des cancers du r\u00e9seau Francim. Partie 1 \u2013\u00a0Tumeurs solides","article-title":"Estimation nationale de l\u2019incidence et de la mortalit\u00e9 par cancer en France entre 1980\u00a0et 2012","author":"Binder-Foucard","year":"2013"},{"key":"10.1016\/j.canrad.2014.11.011_bib0010","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/1097-0142(19840315)53:6<1354::AID-CNCR2820530623>3.0.CO;2-J","article-title":"Patterns of pelvic recurrence following definitive resections of rectal cancer","volume":"53","author":"Pilipshen","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2014.11.011_bib0015","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/1097-0142(19831001)52:7<1317::AID-CNCR2820520731>3.0.CO;2-6","article-title":"Patterns of recurrence of rectal cancer after potentially curative surgery","volume":"52","author":"Rich","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2014.11.011_bib0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0748-7983(98)93500-4","article-title":"Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands","volume":"24","author":"Kapiteijn","year":"1998","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"Van Gijn","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2014.11.011_bib0035","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2014.11.011_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2003.12.006","article-title":"Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomized trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy","volume":"72","author":"Bujko","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0045","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0050","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2014.11.011_bib0055","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3\u20134 rectal cancers: results of FFCD 9203","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study","volume":"15","author":"Bosset","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0065","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1200\/JCO.2005.02.113","article-title":"Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results: EORTC 22921","volume":"23","author":"Bosset","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0070","first-page":"728","article-title":"Anatomo-pathological factors in the prognosis of rectal cancers. A mono- and multifactorial study","volume":"10","author":"Bosset","year":"1986","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0075","series-title":"Radioth\u00e9rapie postop\u00e9ratoire dans les cancers du rectum stades B et C de Dukes","author":"Meneveau","year":"1994"},{"key":"10.1016\/j.canrad.2014.11.011_bib0080","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","article-title":"Preoperative chemoradiotherapy and postoperative chemotherapy with fluoroucil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial","volume":"13","author":"R\u00f6del","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0085","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1200\/JCO.2010.34.4911","article-title":"Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial","volume":"29","author":"Aschele","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0090","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","article-title":"Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12\/0405-Prodige 2","volume":"28","author":"G\u00e9rard","year":"2010","journal-title":"J Clin Oncol"},{"issue":"Suppl.","key":"10.1016\/j.canrad.2014.11.011_bib0095","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/jco.2011.29.15_suppl.3503","article-title":"The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04","volume":"15","author":"Roh","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1470-2045(12)70116-X","article-title":"Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial","volume":"13","author":"Hofheinz","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijrobp.2006.04.007","article-title":"A phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer","volume":"66","author":"Navarro","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.11.011_bib0110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjc.6603570","article-title":"A phase I\/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study","volume":"96","author":"Glynne-Jones","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2014.11.011_bib0115","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.bjc.6603053","article-title":"Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I\/II study","volume":"94","author":"Klautke","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2014.11.011_bib0120","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.ijrobp.2006.07.005","article-title":"Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer","volume":"66","author":"Hofheinz","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.11.011_bib0125","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/annonc\/mdl460","article-title":"Phase I\/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer","volume":"18","author":"Machiels","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0130","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ijrobp.2013.09.011","article-title":"Preoperative chemoradiation therapy with capecitabine\/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1\/2 study","volume":"87","author":"Fokas","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.11.011_bib0135","doi-asserted-by":"crossref","first-page":"8136","DOI":"10.1200\/JCO.2005.02.5635","article-title":"Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients","volume":"23","author":"Willett","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0140","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijrobp.2007.02.001","article-title":"Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: phase I trial results","volume":"68","author":"Czito","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.11.011_bib0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2010.08.005","article-title":"Neoadjuvant bevacizumab, oxaliplatin, 5-fluorouracil, and radiation for rectal cancer","volume":"8","author":"Dipetrillo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl. 9","key":"10.1016\/j.canrad.2014.11.011_bib0150","first-page":"607P","article-title":"Efficacy and safety of two neoadjuvant strategies with bevacizumab in locally advanced respectable rectal cancer: interim results of a randomized, non-comparative phase II study","volume":"23","author":"Bosset","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0155","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.canrad.2011.05.006","article-title":"Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies","volume":"15","author":"Cr\u00e9hange","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.11.011_bib0160","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.1999.17.8.2396","article-title":"Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial","volume":"17","author":"Francois","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.canrad.2006.08.004","article-title":"Preoperative treatment impact for ultralow rectal carcinoma sphincter preservation","volume":"10","author":"Rouanet","year":"2006","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.11.011_bib0170","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1200\/JCO.2007.11.9685","volume":"25","author":"Collette","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00000421-200104000-00001","article-title":"Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer","volume":"24","author":"Janjan","year":"2001","journal-title":"Am J Clin Oncol"},{"issue":"Suppl.","key":"10.1016\/j.canrad.2014.11.011_bib0180","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.1016\/j.ijrobp.2004.07.095","article-title":"Is postoperative adjuvant chemotherapy necessary in locally advanced rectal cancers after preoperative chemoradiation?","volume":"60","author":"Chan","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.11.011_bib0185","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.coc.0000214930.78200.4a","article-title":"Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer","volume":"29","author":"Das","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0190","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/S0140-6736(07)61866-2","article-title":"Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study","volume":"370","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2014.11.011_bib0195","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2014.11.011_bib0200","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.canrad.2011.06.002","article-title":"Chemotherapy and rectal cancer","volume":"15","author":"Michel","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.11.011_bib0205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.canrad.2013.06.043","article-title":"Challenges in the neoadjuvant treatment of rectal cancer: balancing the risk of recurrence and quality of life","volume":"17","author":"Glynne-Jones","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.11.011_bib0210","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus non-operative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2014.11.011_bib0215","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0360-3016(01)02643-8","article-title":"Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer","volume":"52","author":"R\u00f6del","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.11.011_bib0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejso.2005.09.010","article-title":"Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy","volume":"32","author":"Smith","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.canrad.2014.11.011_bib0225","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijrobp.2009.04.030","article-title":"Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging","volume":"77","author":"Janssen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.11.011_bib0230","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ijrobp.2010.11.038","article-title":"PET-based treatment response evaluation in rectal cancer: prediction and validation","volume":"82","author":"Janssen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.11.011_bib0235","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.38937.646400.55","article-title":"Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study","volume":"333","author":"MERCURY Study Group","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.canrad.2014.11.011_bib0240","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1470-2045(07)70202-4","article-title":"Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer","volume":"8","author":"O\u2019Neill","year":"2007","journal-title":"Lancet Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321815000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321815000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:23:27Z","timestamp":1761135807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321815000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1278321815000104"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2014.11.011","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimioradioth\u00e9rapie pr\u00e9op\u00e9ratoire du cancer du rectum\u00a0: exp\u00e9rience d\u2019un centre","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2014.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}